Global Blood Therapeutics | search
Click here to view Global Blood Therapeutics news from 60+ newspapers.
Bookmark or Share- Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion ...Aug 8 (Reuters) - Pfizer Inc on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics (GBT.O), as it looks to capitalize on a surge in revenue...
- Pfizer Completes Acquisition of Global Blood TherapeuticsAcquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community.
- Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance ...Leveraging its global platform, Pfizer plans to accelerate distribution of GBT’s innovative treatment to parts of the world most impacted by SCD.
- Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance ...Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities, starting with sickle cell disease (SCD).
- Pfizer to Buy Global Blood Therapeutics in $5.4 Billion DealPfizer Inc. has agreed to buy Global Blood Therapeutics Inc., the maker of a drug for sickle-cell disease, in a deal worth $5.4 billion. The New York drug giant will pay $68.50 for each...
More
